Comerica Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $539K | Sell |
1,549
-235
| -13% | -$81.7K | 0.04% | 268 |
|
|
2023
Q2 | $628K | Buy |
1,784
+14
| +0.8% | +$4.93K | 0.04% | 274 |
|
|
2023
Q1 | $558K | Sell |
1,770
-422
| -19% | -$133K | 0.04% | 285 |
|
|
2022
Q4 | $633K | Sell |
2,192
-89
| -4% | -$25.7K | 0.05% | 274 |
|
|
2022
Q3 | $660K | Buy |
2,281
+58
| +3% | +$16.8K | 0.05% | 254 |
|
|
2022
Q2 | $626K | Sell |
2,223
-758
| -25% | -$213K | 0.05% | 276 |
|
|
2022
Q1 | $778K | Sell |
2,981
-296
| -9% | -$77.3K | 0.05% | 272 |
|
|
2021
Q4 | $720K | Buy |
3,277
+300
| +10% | +$65.9K | 0.05% | 277 |
|
|
2021
Q3 | $540K | Buy |
2,977
+116
| +4% | +$21K | 0.04% | 304 |
|
|
2021
Q2 | $577K | Buy |
2,861
+798
| +39% | +$161K | 0.04% | 293 |
|
|
2021
Q1 | $443K | Buy |
2,063
+558
| +37% | +$120K | 0.03% | 334 |
|
|
2020
Q4 | $356K | Buy |
1,505
+369
| +32% | +$87.3K | 0.03% | 350 |
|
|
2020
Q3 | $309K | Buy |
1,136
+265
| +30% | +$72.1K | 0.03% | 345 |
|
|
2020
Q2 | $253K | Sell |
871
-3
| -0.3% | -$871 | 0.02% | 366 |
|
|
2020
Q1 | $208K | Buy |
+874
| New | +$208K | 0.02% | 374 |
|
|
2017
Q1 | – | Sell |
-6,605
| Closed | -$487K | – | 408 |
|
|
2016
Q4 | $487K | Buy |
6,605
+181
| +3% | +$13.3K | 0.2% | 123 |
|
|
2016
Q3 | $560K | Buy |
+6,424
| New | +$560K | 0.24% | 105 |
|